In April, 2019 a new Multiple Sclerosis medication was released to the public with an official indication of relapsing MS. The new medication was shown in large studies to significantly reduce the number of relapses in patients. While there are many promising benefits to the medication, it obviously like all drugs, will have a downside of risks. Here is information on Mavenclad https://www.medicinenet.com/script/main/art.asp?articlekey=219879
Has anyone had experience with Mavenclad or have any information to share about it?